Skip to main content
. 2017 Jul 31;8(38):64283–64293. doi: 10.18632/oncotarget.19724

Figure 1. Percentage of tumor cells and percentage of tumor areas infiltrated with immune cells with expression of PD-L1 (% TPS) depending on antibody clones used in IHC technique.

Figure 1